Folic acid supplements and perinatal mortality in China.

early neonatal death folic acid supplementation neonatal death perinatal mortality stillbirth

Journal

Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264

Informations de publication

Date de publication:
2023
Historique:
received: 12 09 2023
accepted: 18 12 2023
medline: 23 1 2024
pubmed: 23 1 2024
entrez: 23 1 2024
Statut: epublish

Résumé

Periconceptional use of multivitamins containing folic acid prevents external major birth defects, especially neural tube defects. We aimed to explore the effects of maternal folic acid supplementation alone on perinatal mortality with or without external major birth defects plus neural tube defects. From the China-US Collaborative Project for Neural Tube Defects Prevention, we identified 222, 303 singleton pregnancies with detailed information on periconceptional folic acid use, defined as folic acid supplementary before the last menstrual date until to the end of the first trimester. Perinatal mortality included stillbirths after 20 weeks' gestation and early neonatal deaths within 7 days of delivery. Among the fetuses or infants of women who did not take folic acid, the rate of perinatal mortality was 2.99% and 1.62% at least 20 weeks' gestation in the northern and southern regions. Among the fetuses or infants of the women with periconceptional use of folic acid, the rates were 1.85% and 1.39% in the northern and southern region. The estimated relative risk for perinatal mortality [adjusted risk ratio (RR), 0.72; 95% confidence interval (CI), 0.61- 0.85], stillbirth (adjusted RR, 0.78; 95% CI, 0.64-0.96), early neonatal mortality (adjusted RR, 0.61; 95% CI, 0.45-0.82), and neonatal death (adjusted RR, 0.64; 95% CI, 0.49-0.83) in northern China was significantly decreased in association with periconceptional folic acid supplementation. Compared with northern, there was a lesser effect in southern China. Periconceptional intake of 400μg folic acid daily reduces the overall risk perinatal mortality, as well as the risk from external major birth defects and neural tube defects, especially in northern China.

Identifiants

pubmed: 38260077
doi: 10.3389/fnut.2023.1281971
pmc: PMC10800445
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1281971

Informations de copyright

Copyright © 2024 Liu, Liu, An, Li, Zhang, Zhang, Liu, Ye and Li.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Xiaojing Liu (X)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
Institute of Reproductive and Child Health/Ministry of Health Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing, China.

Xiaowen Liu (X)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
Institute of Reproductive and Child Health/Ministry of Health Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing, China.

Hang An (H)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
Institute of Reproductive and Child Health/Ministry of Health Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing, China.

Zhiwen Li (Z)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
Institute of Reproductive and Child Health/Ministry of Health Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing, China.

Le Zhang (L)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
Institute of Reproductive and Child Health/Ministry of Health Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing, China.

Yali Zhang (Y)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
Institute of Reproductive and Child Health/Ministry of Health Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing, China.

Jianmeng Liu (J)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
Institute of Reproductive and Child Health/Ministry of Health Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing, China.

Rongwei Ye (R)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
Institute of Reproductive and Child Health/Ministry of Health Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing, China.

Nan Li (N)

Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
Institute of Reproductive and Child Health/Ministry of Health Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing, China.

Classifications MeSH